Anavex Life Sciences Doses First Patient in Phase 2 Clinical Trial of ANAVEX®2-73 for the Treatment of Rett Syndrome Biotech Investing
RTI Surgical Implants 5,000th Fortilink Interbody Fusion Systems with TETRAfuse 3D Technology Medical Device Investing
Obalon Announces Issuance of First U.S. Patent Covering Its Proprietary Navigation System Medical Device Investing
Green Growth Brands Continues Rapid Expansion of MSO Business Through Agreement to Acquire Florida Based Spring Oaks Cannabis Investing News
